|
A Clinical Assay Named EvIPThT
Cancer detection methods traditionally rely on invasive procedures or single-marker assays that often yield false positives. This technology introduces a novel method for identifying tumor-derived extracellular vesicles (EVs) through antibody binding and beta-sheet structure analysis.
The process involves:
Combining an antibody with a sample to...
Published: 11/25/2025
|
Inventor(s): Dali Sun
Keywords(s):
Category(s): Technologies, Technologies > Biology & Medicine
|
